nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Epirubicin—Doxorubicin—muscle cancer	0.0457	1	CbGdCrCtD
Emtricitabine—Neuritis—Vincristine—muscle cancer	0.0152	0.0159	CcSEcCtD
Emtricitabine—Osteonecrosis—Methotrexate—muscle cancer	0.0148	0.0155	CcSEcCtD
Emtricitabine—Opportunistic infection—Methotrexate—muscle cancer	0.0137	0.0143	CcSEcCtD
Emtricitabine—Bone pain—Vincristine—muscle cancer	0.0118	0.0124	CcSEcCtD
Emtricitabine—Opportunistic infection—Doxorubicin—muscle cancer	0.0118	0.0124	CcSEcCtD
Emtricitabine—Neuropathy—Vincristine—muscle cancer	0.0106	0.0112	CcSEcCtD
Emtricitabine—Urine output increased—Vincristine—muscle cancer	0.0103	0.0107	CcSEcCtD
Emtricitabine—Skin discolouration—Etoposide—muscle cancer	0.0102	0.0107	CcSEcCtD
Emtricitabine—Inflammation—Etoposide—muscle cancer	0.00947	0.00993	CcSEcCtD
Emtricitabine—Multiple fractures—Methotrexate—muscle cancer	0.00947	0.00992	CcSEcCtD
Emtricitabine—Fracture—Methotrexate—muscle cancer	0.00947	0.00992	CcSEcCtD
Emtricitabine—Polyuria—Vincristine—muscle cancer	0.00938	0.00983	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Methotrexate—muscle cancer	0.00925	0.0097	CcSEcCtD
Emtricitabine—Neuropathy—Etoposide—muscle cancer	0.00863	0.00904	CcSEcCtD
Emtricitabine—Vesiculobullous rash—Doxorubicin—muscle cancer	0.0085	0.00891	CcSEcCtD
Emtricitabine—Rash maculo-papular—Etoposide—muscle cancer	0.00835	0.00875	CcSEcCtD
Emtricitabine—Hypophosphataemia—Doxorubicin—muscle cancer	0.0082	0.00859	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.00801	0.0084	CcSEcCtD
Emtricitabine—Neutropenia—Dactinomycin—muscle cancer	0.00745	0.0078	CcSEcCtD
Emtricitabine—Muscular weakness—Vincristine—muscle cancer	0.00726	0.00761	CcSEcCtD
Emtricitabine—Pneumonia—Dactinomycin—muscle cancer	0.00714	0.00748	CcSEcCtD
Emtricitabine—Hepatomegaly—Doxorubicin—muscle cancer	0.00673	0.00705	CcSEcCtD
Emtricitabine—Neutropenia—Vincristine—muscle cancer	0.00665	0.00697	CcSEcCtD
Emtricitabine—Weight decreased—Vincristine—muscle cancer	0.00644	0.00675	CcSEcCtD
Emtricitabine—Neuritis—Doxorubicin—muscle cancer	0.00638	0.00669	CcSEcCtD
Emtricitabine—Pneumonia—Vincristine—muscle cancer	0.00638	0.00669	CcSEcCtD
Emtricitabine—Hepatitis—Dactinomycin—muscle cancer	0.00637	0.00668	CcSEcCtD
Emtricitabine—Pharyngitis—Dactinomycin—muscle cancer	0.00633	0.00663	CcSEcCtD
Emtricitabine—Depression—Vincristine—muscle cancer	0.00633	0.00663	CcSEcCtD
Emtricitabine—Proteinuria—Methotrexate—muscle cancer	0.00626	0.00656	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Vincristine—muscle cancer	0.00622	0.00652	CcSEcCtD
Emtricitabine—Protein urine present—Methotrexate—muscle cancer	0.00618	0.00647	CcSEcCtD
Emtricitabine—Otitis media—Doxorubicin—muscle cancer	0.00612	0.00641	CcSEcCtD
Emtricitabine—Skin discolouration—Methotrexate—muscle cancer	0.00609	0.00638	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.00605	0.00634	CcSEcCtD
Emtricitabine—Rash pustular—Doxorubicin—muscle cancer	0.00597	0.00626	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00588	0.00616	CcSEcCtD
Emtricitabine—Glycosuria—Doxorubicin—muscle cancer	0.00588	0.00616	CcSEcCtD
Emtricitabine—Inflammation—Methotrexate—muscle cancer	0.00567	0.00595	CcSEcCtD
Emtricitabine—Urinary tract disorder—Vincristine—muscle cancer	0.00562	0.00589	CcSEcCtD
Emtricitabine—Connective tissue disorder—Vincristine—muscle cancer	0.0056	0.00586	CcSEcCtD
Emtricitabine—Urethral disorder—Vincristine—muscle cancer	0.00558	0.00585	CcSEcCtD
Emtricitabine—Neutropenia—Etoposide—muscle cancer	0.00539	0.00565	CcSEcCtD
Emtricitabine—Skin discolouration—Doxorubicin—muscle cancer	0.00528	0.00553	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.00524	0.00549	CcSEcCtD
Emtricitabine—Cough increased—Doxorubicin—muscle cancer	0.00521	0.00545	CcSEcCtD
Emtricitabine—Pneumonia—Etoposide—muscle cancer	0.00517	0.00542	CcSEcCtD
Emtricitabine—Infestation NOS—Etoposide—muscle cancer	0.00514	0.00539	CcSEcCtD
Emtricitabine—Infestation—Etoposide—muscle cancer	0.00514	0.00539	CcSEcCtD
Emtricitabine—Mediastinal disorder—Vincristine—muscle cancer	0.00513	0.00538	CcSEcCtD
Emtricitabine—Anaemia—Dactinomycin—muscle cancer	0.00513	0.00537	CcSEcCtD
Emtricitabine—Renal failure—Etoposide—muscle cancer	0.00505	0.00529	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Etoposide—muscle cancer	0.00504	0.00528	CcSEcCtD
Emtricitabine—Creatinine increased—Doxorubicin—muscle cancer	0.00501	0.00525	CcSEcCtD
Emtricitabine—Mental disorder—Vincristine—muscle cancer	0.00499	0.00523	CcSEcCtD
Emtricitabine—Urine output increased—Methotrexate—muscle cancer	0.00498	0.00521	CcSEcCtD
Emtricitabine—Bone pain—Doxorubicin—muscle cancer	0.00497	0.00521	CcSEcCtD
Emtricitabine—Inflammation—Doxorubicin—muscle cancer	0.00491	0.00515	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Etoposide—muscle cancer	0.00486	0.00509	CcSEcCtD
Emtricitabine—Back pain—Vincristine—muscle cancer	0.0048	0.00503	CcSEcCtD
Emtricitabine—Myalgia—Dactinomycin—muscle cancer	0.00472	0.00495	CcSEcCtD
Emtricitabine—Abnormal dreams—Doxorubicin—muscle cancer	0.00471	0.00493	CcSEcCtD
Emtricitabine—Anaemia—Vincristine—muscle cancer	0.00458	0.0048	CcSEcCtD
Emtricitabine—Urinary tract disorder—Etoposide—muscle cancer	0.00456	0.00477	CcSEcCtD
Emtricitabine—Polyuria—Methotrexate—muscle cancer	0.00455	0.00477	CcSEcCtD
Emtricitabine—Urethral disorder—Etoposide—muscle cancer	0.00452	0.00474	CcSEcCtD
Emtricitabine—Infection—Dactinomycin—muscle cancer	0.0045	0.00471	CcSEcCtD
Emtricitabine—Neuropathy—Doxorubicin—muscle cancer	0.00447	0.00469	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00443	0.00465	CcSEcCtD
Emtricitabine—Rash maculo-papular—Doxorubicin—muscle cancer	0.00433	0.00454	CcSEcCtD
Emtricitabine—Renal failure acute—Methotrexate—muscle cancer	0.00433	0.00453	CcSEcCtD
Emtricitabine—Myalgia—Vincristine—muscle cancer	0.00422	0.00442	CcSEcCtD
Emtricitabine—Immune system disorder—Etoposide—muscle cancer	0.00417	0.00437	CcSEcCtD
Emtricitabine—Mediastinal disorder—Etoposide—muscle cancer	0.00416	0.00436	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00413	0.00432	CcSEcCtD
Emtricitabine—Infection—Vincristine—muscle cancer	0.00402	0.00421	CcSEcCtD
Emtricitabine—Nervous system disorder—Vincristine—muscle cancer	0.00397	0.00416	CcSEcCtD
Emtricitabine—Thrombocytopenia—Vincristine—muscle cancer	0.00396	0.00415	CcSEcCtD
Emtricitabine—Fatigue—Dactinomycin—muscle cancer	0.0039	0.00409	CcSEcCtD
Emtricitabine—Back pain—Etoposide—muscle cancer	0.00388	0.00407	CcSEcCtD
Emtricitabine—Pain—Dactinomycin—muscle cancer	0.00387	0.00406	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—muscle cancer	0.00375	0.00393	CcSEcCtD
Emtricitabine—Anaemia—Etoposide—muscle cancer	0.00371	0.00389	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0037	0.00388	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00369	0.00386	CcSEcCtD
Emtricitabine—Insomnia—Vincristine—muscle cancer	0.00366	0.00384	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—muscle cancer	0.00363	0.00381	CcSEcCtD
Emtricitabine—Paraesthesia—Vincristine—muscle cancer	0.00363	0.00381	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—muscle cancer	0.00362	0.00379	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—muscle cancer	0.00361	0.00378	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—muscle cancer	0.00358	0.00375	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—muscle cancer	0.00358	0.00375	CcSEcCtD
Emtricitabine—Cough—Etoposide—muscle cancer	0.0035	0.00367	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00349	0.00366	CcSEcCtD
Emtricitabine—Fatigue—Vincristine—muscle cancer	0.00349	0.00366	CcSEcCtD
Emtricitabine—Pain—Vincristine—muscle cancer	0.00346	0.00363	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0034	0.00356	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—muscle cancer	0.00338	0.00355	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—muscle cancer	0.00334	0.0035	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Vincristine—muscle cancer	0.00331	0.00347	CcSEcCtD
Emtricitabine—Infection—Etoposide—muscle cancer	0.00326	0.00341	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—muscle cancer	0.00325	0.00341	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—muscle cancer	0.00324	0.0034	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—muscle cancer	0.00323	0.00338	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—muscle cancer	0.00321	0.00336	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00321	0.00336	CcSEcCtD
Emtricitabine—Abdominal pain—Vincristine—muscle cancer	0.0032	0.00335	CcSEcCtD
Emtricitabine—Body temperature increased—Vincristine—muscle cancer	0.0032	0.00335	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—muscle cancer	0.00318	0.00334	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—muscle cancer	0.00315	0.0033	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—muscle cancer	0.00313	0.00328	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—muscle cancer	0.0031	0.00325	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—muscle cancer	0.0031	0.00324	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—muscle cancer	0.00309	0.00324	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—muscle cancer	0.00308	0.00323	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—muscle cancer	0.00308	0.00323	CcSEcCtD
Emtricitabine—Depression—Methotrexate—muscle cancer	0.00307	0.00322	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00305	0.0032	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—muscle cancer	0.00305	0.0032	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—muscle cancer	0.00303	0.00317	CcSEcCtD
Emtricitabine—Hypersensitivity—Vincristine—muscle cancer	0.00298	0.00312	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—muscle cancer	0.00294	0.00308	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—muscle cancer	0.00294	0.00308	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—muscle cancer	0.00293	0.00307	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—muscle cancer	0.00292	0.00306	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00291	0.00305	CcSEcCtD
Emtricitabine—Asthenia—Vincristine—muscle cancer	0.0029	0.00304	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—muscle cancer	0.00288	0.00302	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—muscle cancer	0.00286	0.00299	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00283	0.00297	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—muscle cancer	0.00283	0.00296	CcSEcCtD
Emtricitabine—Pain—Etoposide—muscle cancer	0.0028	0.00294	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—muscle cancer	0.0028	0.00293	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00278	0.00291	CcSEcCtD
Emtricitabine—Diarrhoea—Vincristine—muscle cancer	0.00277	0.0029	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—muscle cancer	0.00276	0.0029	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—muscle cancer	0.00274	0.00287	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—muscle cancer	0.00273	0.00286	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—muscle cancer	0.00271	0.00284	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—muscle cancer	0.0027	0.00283	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—muscle cancer	0.0027	0.00283	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—muscle cancer	0.00269	0.00282	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—muscle cancer	0.00268	0.00281	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—muscle cancer	0.00268	0.00281	CcSEcCtD
Emtricitabine—Dizziness—Vincristine—muscle cancer	0.00268	0.0028	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—muscle cancer	0.00267	0.00279	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—muscle cancer	0.00267	0.00279	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—muscle cancer	0.00262	0.00275	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00261	0.00274	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—muscle cancer	0.0026	0.00273	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—muscle cancer	0.00259	0.00272	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—muscle cancer	0.00259	0.00272	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—muscle cancer	0.00259	0.00272	CcSEcCtD
Emtricitabine—Vomiting—Vincristine—muscle cancer	0.00257	0.0027	CcSEcCtD
Emtricitabine—Rash—Vincristine—muscle cancer	0.00255	0.00267	CcSEcCtD
Emtricitabine—Dermatitis—Vincristine—muscle cancer	0.00255	0.00267	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—muscle cancer	0.00254	0.00266	CcSEcCtD
Emtricitabine—Headache—Vincristine—muscle cancer	0.00253	0.00266	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00252	0.00264	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—muscle cancer	0.0025	0.00262	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—muscle cancer	0.0025	0.00262	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—muscle cancer	0.00249	0.00261	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—muscle cancer	0.00242	0.00254	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—muscle cancer	0.00241	0.00253	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—muscle cancer	0.00241	0.00252	CcSEcCtD
Emtricitabine—Nausea—Vincristine—muscle cancer	0.0024	0.00252	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—muscle cancer	0.0024	0.00251	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—muscle cancer	0.00239	0.00251	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—muscle cancer	0.00237	0.00249	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00236	0.00248	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—muscle cancer	0.00235	0.00246	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—muscle cancer	0.00235	0.00246	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—muscle cancer	0.00235	0.00246	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—muscle cancer	0.00233	0.00244	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—muscle cancer	0.00232	0.00243	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—muscle cancer	0.00224	0.00235	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—muscle cancer	0.00222	0.00233	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—muscle cancer	0.00217	0.00227	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—muscle cancer	0.00216	0.00226	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00216	0.00226	CcSEcCtD
Emtricitabine—Cough—Methotrexate—muscle cancer	0.0021	0.0022	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—muscle cancer	0.0021	0.0022	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—muscle cancer	0.00208	0.00218	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—muscle cancer	0.00208	0.00218	CcSEcCtD
Emtricitabine—Rash—Etoposide—muscle cancer	0.00207	0.00217	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—muscle cancer	0.00206	0.00216	CcSEcCtD
Emtricitabine—Headache—Etoposide—muscle cancer	0.00205	0.00215	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—muscle cancer	0.00205	0.00215	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—muscle cancer	0.00205	0.00215	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00203	0.00213	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—muscle cancer	0.00201	0.00211	CcSEcCtD
Emtricitabine—Infection—Methotrexate—muscle cancer	0.00195	0.00204	CcSEcCtD
Emtricitabine—Nausea—Etoposide—muscle cancer	0.00195	0.00204	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—muscle cancer	0.00193	0.00202	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—muscle cancer	0.00193	0.00202	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—muscle cancer	0.00192	0.00201	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—muscle cancer	0.00191	0.002	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—muscle cancer	0.00182	0.0019	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00179	0.00187	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—muscle cancer	0.00178	0.00186	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—muscle cancer	0.00177	0.00186	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—muscle cancer	0.00177	0.00186	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—muscle cancer	0.00177	0.00185	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—muscle cancer	0.00176	0.00185	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00176	0.00185	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—muscle cancer	0.00175	0.00183	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—muscle cancer	0.00173	0.00181	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0017	0.00178	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—muscle cancer	0.00169	0.00177	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—muscle cancer	0.00169	0.00177	CcSEcCtD
Emtricitabine—Pain—Methotrexate—muscle cancer	0.00168	0.00176	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—muscle cancer	0.00167	0.00175	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—muscle cancer	0.00166	0.00174	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—muscle cancer	0.00165	0.00173	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00161	0.00168	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—muscle cancer	0.00156	0.00163	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—muscle cancer	0.00155	0.00163	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—muscle cancer	0.00155	0.00163	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00155	0.00162	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—muscle cancer	0.00154	0.00161	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—muscle cancer	0.00153	0.0016	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—muscle cancer	0.00152	0.00159	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—muscle cancer	0.0015	0.00157	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00147	0.00154	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—muscle cancer	0.00147	0.00154	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—muscle cancer	0.00145	0.00152	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—muscle cancer	0.00145	0.00152	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—muscle cancer	0.00141	0.00148	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00139	0.00146	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—muscle cancer	0.00139	0.00146	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—muscle cancer	0.00135	0.00142	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—muscle cancer	0.00134	0.00141	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—muscle cancer	0.00134	0.00141	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—muscle cancer	0.00134	0.00141	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—muscle cancer	0.0013	0.00136	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—muscle cancer	0.00125	0.00131	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—muscle cancer	0.00125	0.00131	CcSEcCtD
Emtricitabine—Rash—Methotrexate—muscle cancer	0.00124	0.0013	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—muscle cancer	0.00124	0.0013	CcSEcCtD
Emtricitabine—Headache—Methotrexate—muscle cancer	0.00123	0.00129	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—muscle cancer	0.00122	0.00128	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—muscle cancer	0.0012	0.00126	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—muscle cancer	0.00117	0.00122	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—muscle cancer	0.00116	0.00122	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—muscle cancer	0.00112	0.00118	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—muscle cancer	0.00108	0.00113	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—muscle cancer	0.00107	0.00112	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—muscle cancer	0.00107	0.00112	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—muscle cancer	0.00107	0.00112	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—muscle cancer	0.00101	0.00106	CcSEcCtD
